Organisation
Molecular Imaging, Pathology, Radiotherapy & Oncology (MIPRO)
Research Group
Projects
1 - 10 of 161
- Development of novel TCO probes for pretargeted intracellular PET imaging.From1 Oct 2018 → 31 Oct 2019Funding: BOF - Other initiatives
- Targeting Polo-like kinase 1 for treatment of NSCLC patients: focus on the induction of cellular senescence, the TP53 status and hypoxia.From1 Oct 2018 → 30 Sep 2022Funding: BOF - Doctoral projects
- Plasma-treated liquids for cancer treatment: elucidating the selectivity against cancer cells by a combined experimental and computational study.From1 Oct 2018 → 31 Jan 2019Funding: FWO fellowships
- Study towards molecular heterogeneity of circulating tumor cells and their representation of metastatic sites in patients with metastatic breast cancer.From1 Oct 2018 → 30 Sep 2021Funding: FWO fellowships
- Imaging of receptor activator of the nuclear factor κ B ligand (RANKL) tumor microenvironment using immuno-positron emission tomography (PET) in models of head-and-neck and breast cancer.From1 Oct 2018 → 30 Sep 2022Funding: BOF - Doctoral projects
- Exploring the potential and underlying mechanisms of therapeutic activation of p53 in combination with immunotherapy to stimulate an innate immune response against non-small cell lung cancer.From1 Oct 2018 → 30 Sep 2020Funding: FWO fellowships
- The role of infiltrating immune cells in the aggresive phenotype of inflammatory breast cancer and possible new (immuno)therapeutic targets.From1 Oct 2018 → 30 Sep 2020Funding: FWO fellowships
- Development of novel cell death PET imaging probes for early treatment response assessment.From1 Oct 2018 → 30 Sep 2022Funding: BOF - Doctoral projects
- Developing a novel synergistic approach of chemotherapy and immunotherapy to enhance the anti-tumor immune response in non-small cell lung cancer.From1 Oct 2018 → 30 Sep 2022Funding: BOF - Doctoral projects
- Research in the field of oncology.From1 Oct 2018 → TodayFunding: BOF - ZAP BOF mandates, BOF - Research professorship
Publications
21 - 30 of 1626
- Metric for fast automated relative assessment of motion correction methods for dynamic PET imaging(2012)
Authors: S. Hafezian, J. Cottitto, A.J. Reader, Jeroen Verhaeghe
Number of pages: 1 - Effect of food on the pharmacokinetics of olaparib after oral dosing of the capsule formulation in patients with advanced solid tumors(2015)
Authors: Christian Rolfo, Helen Swaisland, Karin Leunen, Annemie Rutten, Patricia Soetekouw, Sarah Slater, Henk M. W. Verheul, Anitra Fielding, Karen So, Wendy Bannister, et al.
Pages: 510 - 522 - Randomized phase II study of Duligotuzumab (MEHD7945A) vs. Cetuximab in squamous cell carcinoma of the head and neck (MEHGAN Study)(2016)
Authors: Jerome Fayette, Lori Wirth, Cristina Oprean, Anghel Udrea, Antonio Jimeno, Danny Rischin, Christopher Nutting, Paul M. Harari, Tibor Csoszi, Dana Cernea, et al.
- Longitudinal quantification of inflammation in the murine dextran sodium sulfate-induced colitis model using $\mu PET/CT$(2011)
Authors: P. Hindryckx, Steven Staelens, L. Devisscher, Steven Deleye, F. de Vos, L. Delrue, H. Peeters, D. Laukens, M. de Vos
Pages: 2058 - 2064 - Evaluation of the optimal combinations of modulation factor and pitch for Helical TomoTherapy plans made with TomoEdge using Pareto optimal fronts(2015)
Authors: Geert De Kerf, Dirk Van Gestel, Lobke Mommaerts, Danielle Van den Weyngaert
- KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target(2018)
Authors: Marta Roman, Iosune Baraibar, Ines Lopez, Ernest Nadal, Christian Rolfo, Silvestre Vicent, Ignacio Gil-Bazo
- Moving osimertinib to first-line(2018)
Authors: Francesco Passiglia, Luis E. Raez, Christian Rolfo
Pages: S1076 - S1080 - Safety and efficacy of temsirolimus under compassionate use in heavily pretreated patients with poor-prognosis solid tumors(2015)
Authors: J. P. Fusco, Christian Rolfo, E. Castanon, L. Ceniceros, J. Legaspi, J. Espinos, J. Rodriguez, J. M. Aramendia, M. Santisteban, I. Gil-Bazo
Pages: 495 - 498 - Resistance mechanisms to AZD9291 and Rociletinib-letter(2017)
Authors: Nele Van Der Steen, Christian Rolfo, Patrick Pauwels, Adrianus J. de Langen, Godefridus J. Peters, Elisa Giovannetti
Pages: 3966 - 3966 - Crizotinib sensitizes the erlotinib resistant HCC827GR5 cell line by influencing lysosomal function(2020)
Authors: Nele Van Der Steen, Kaylee Keller, Henk Dekker, Letizia Porcelli, Richard J. Honeywell, Johan Van Meerloo, Rene J. P. Musters, Ietje Kathmann, Adam E. Frampton, Daniel S. K. Liu, et al.